Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients

Background: Tissue plasminogen activator (tPA) has been long approved as an efficacious treatment in patients with acute ischemic stroke (AIS); however, due to some serious complications, particularly intracranial hemorrhage (ICH), many physicians are still reluctant to use it liberally. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi-Hokmabadi, Elyar, Yazdchi, Mohammad, Farhoudi, Mehdi, Sadeghi, Homayoun, Taheraghdam, Aliakbar, Rikhtegar, Reza, Aliyar, Hannaneh, Mohammadi-Fallah, Sahar, Asadi, Rogayyeh, Mehdizadeh-Far, Elham, Ghaemian, Neda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121208/
https://www.ncbi.nlm.nih.gov/pubmed/30186557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6121208/
https://www.ncbi.nlm.nih.gov/pubmed/30186557

Ejemplares similares